Louis Ploth Jr. is CFO at REPROS THERAPEUTICS INC. (RPRX). They have made 6 open-market trades across 1 company since 2006, most recently 2008-10-07.
CIK 0001197577
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $61K since 2006, never a sale. Across 6 scored buys the stock is up 1.1% at ninety days, and 0.9 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| RPRX | 40,217 | $2.5M |
Shares reported on the most recent Form 4, priced at the 2008-10-07 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | +18.4% | +1.1% | +1.1% |
| Alpha | -34.8% | +0.9% | +0.9% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RPRX | BUY | 2008-10-07 | 2008-10-07 | $7.15 | $20K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2008-04-22 | 2008-04-22 | $8.77 | $4K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2008-04-16 | 2008-04-16 | $8.76 | $18K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2006-12-01 | 2006-12-01 | $5.90 | $6K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2006-11-28 | 2006-11-28 | $5.72 | $6K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2006-11-01 | 2006-11-02 | $7.95 | $7K | +18.4% | +1.1% | +1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.